Feprazone
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
4-(3-methylbut-2-enyl)-1,2-di(phenyl)pyrazolidine-3,5-dione
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| ATC code | M02AA16 (WHO) |
| PubChem | CID 35455 |
| ChemSpider | 32612  |
| UNII | 7BVX6J0CGR |
| KEGG | D01305 |
| Chemical data | |
| Formula | C20H20N2O2 |
| Molar mass | 320.385 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Feprazone (or prenazone) is a drug used for joint and muscular pain.[1]
It is an analog of butazone but instead of a n-butyl group it is prenylated.
References[edit]
- ^ Koyama, T.; Izawa, Y.; Wada, H.; Makita, T.; Hashimoto, Y.; Enomoto, M. (1982). "Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug". Toxicology and applied pharmacology. 64 (2): 255–270. doi:10.1016/0041-008X(82)90222-8. PMID 7123554.
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
